References
- Canale V, Steinherz P, New M, et al. Endocrine function in thalassemia major. Ann NY Acad Sci. 1974;232:333–345.
- Papakonstantinou O, Ladis V, Kostaridou S, et al. The pancreas in β-thalassemia major: MR imaging features and correlation with iron stores and glucose disturbunces. Eur Radiol. 2007;17(6):1535–1543.
- Kattamis C, Ladis V, Tsoussis D, et al. Evolution of glucose intolerance and diabetes in transfused patients with thalassemia. Pediatr Endocrinol Rev. 2004;2(Suppl2):267–271.
- Cario H, Holl RW, Debatin K-M, et al. Insulin sensitivity and β-cell secretion in thalassaemia major with secondary haemochromatosis: assessment by oral glucose tolerance test. Eur J Pediatr. 2003;162(3):139–146.
- Youssef DM, Fawzy Mohammad F, Ahmed Fathy A, et al. Assessment of hepatic and pancreatic iron overload in pediatric β-thalassemic major patients by t2* weighted gradient echo magnetic resonance imaging. ISRN Hematol. 2013;2013:496985. doi: 10.1155/2013/496985.
- Noetzli LJ, Coates TD, Mittelman SD, et al. Pancreatic iron and pancreatic function in thalassemia. Blood. 2008;112(11):3876–3882.
- Queiroz-Andrade M, Blasbalg R, Ortega CD, et al. MR imaging findings of iron overload 1. Radiographics. 2009;29(6):1575–1589.
- Wood JC. Magnetic resonance imaging measurement of iron overload. Curr Opin Hematol. 2007;14(3):183–190.
- Papakonstantinou O, Alexopoulou E, Economopoulos N, et al. Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with β thalassemia major. J Magn Reson Imaging. 2009;29(4):853–859.
- Wood JC. Impact of iron assessment by MRI. [Review] Hematology Am Soc Hematol Educ Program. 2011;2011:443–50. doi: 10.1182/asheducation-2011.1.443.
- Midiri M, Lo Casto A, Sparacia G, et al. MR imaging of pancreatic changes in patients with transfusion-dependent β-thalassemia major. Am J Roentgenol. 1999;173(1):187–192.
- Au W-Y, Lam WW-M, Chu W, et al. A T2* magnetic resonance imaging study of pancreatic iron overload in thalassemia major. Haematologica. 2008;93(1):116–119.
- Azarkeivan A, Hashemieh M, Shirkavand A, et al. Correlation between heart, liver and pancreas hemosiderosis measured by MRI T2* among thalassemia major patients from Iran. Arch Iranian Med. 2016;19(2):96–100.
- Kolnagou A, Natsiopoulos K, Kleanthous M, et al. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*. Toxicol Mech Methods. 2013;23(1):48–56.
- Matter RM, Allam KE, Sadony AM. Gradient-echo magnetic resonance imaging study of pancreatic iron overload in young Egyptian β-thalassemia major patients and effect of splenectomy. Diabetol Metabol Syndr. 2010;2:23. doi: 10.1186/1758-5996-2-23.
- Noetzli LJ, Carson SM, Nord AS, et al. Longitudinal analysis of heart and liver iron in thalassemia major. Blood. 2008;112(7):2973–2978.
- De Assis RA, Ribeiro AAF, Kay FU, et al. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in β thalassemic patients. Eur J Radiol. 2012;81(7):1465–1470.
- American Diabetes Association, Standards of medical care in diabetes—2016 abridged for primary care providers. Clinical Diabetes: a Publication of the American Diabetes Association. 2016;34(1):13–23.
- Mukaka M. A guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012;24(3):69–71.